drugset / Trial / NCT02407314

Ticagrelor and Peripheral Arterial Disease

NCT02407314 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This is an interventional study assessing the effectiveness of Ticagrelor on the reduction of thrombus burden using optical coherence tomography in patients undergoing peripheral artery stenting.

Timeline

Start
2015-06
Primary completion
2017-01-17
Completion
2017-01-17

Outcome

Outcome not reported

Stopped: “AZ discontinued study”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ticagrelor Small molecule 90 mg —
Comparator Aspirin Small molecule 81 mg —